A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults
Clinical trial NCT05252338 · COMPLETED
Trial details
- NCT number
- NCT05252338
- Sponsor
- CureVac
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2022-09-27
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.